Bruce E. Tomczuk

2.0k citations

37 papers · 1.1k indexed · 1 hit paper · h-index 20

Molecular Biology
Organic Chemistry top 5%
Oncology top 10%
Radiology, Nuclear Medicine and Imaging top 5%
Immunology

Co-authors: Sean W. Smith Nareshkumar Jain Carl Crysler John Spurlino Tianbao Lu Carl L. Manthey Mark R. Player Renée L. DesJarlais
Topics: Peptidase Inhibition and Analysis (8 papers)Chemical Synthesis and Analysis (5 papers)Blood Coagulation and Thrombosis Mechanisms (5 papers)
Cited by: Organic Chemistry Oncology Radiology, Nuclear Medicine and Imaging
Journals: Journal of the American Chemical Society Journal of Medicinal Chemistry Molecular Pharmacology
Partner nations: United States Belgium

In The Last Decade

Bruce E. Tomczuk

37 papers receiving 1.1k citations

Hit Papers

align trajectories

Peers

Countries citing papers authored by Bruce E. Tomczuk

Since Specialization

Citations

This map shows the geographic impact of Bruce E. Tomczuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce E. Tomczuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce E. Tomczuk more than expected).

Fields of papers citing papers by Bruce E. Tomczuk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce E. Tomczuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce E. Tomczuk. The network helps show where Bruce E. Tomczuk may publish in the future.

Co-authorship network of co-authors of Bruce E. Tomczuk

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce E. Tomczuk. A scholar is included among the top collaborators of Bruce E. Tomczuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce E. Tomczuk. Bruce E. Tomczuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Enhancement of kinase selectivity in a potent class of arylamide FMS inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·Carl R. Illig,Carl L. Manthey,Sanath K. Meegalla,Mark J. Wall,(unknown),Kenneth J. Wilson,Renée L. DesJarlais,Shelley K. Ballentine,Carsten J. Schubert,Carl Crysler,Yanmin Chen,Christopher J. Molloy,Margery A. Chaikin,Robert R. Donatelli,Edward J. Yurkow,Zhou Zhao,Mark R. Player,Bruce E. Tomczuk	3
2	Effect of the Mammalian Arginase Inhibitor 2(S)-Amino-6-Boronohexanoic Acid on Bacillus anthracis Arginase 2012 ·Current Microbiology ·Pei Tsai,(unknown),Bruce E. Tomczuk,Peter D. Suzdak,Alan S. Cross,Paul Shapiro,Gerald M. Rosen	2
3	Structure-based optimization of a potent class of arylamide FMS inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Sanath K. Meegalla,Mark J. Wall,(unknown),Kenneth J. Wilson,Shelley K. Ballentine,Renée L. DesJarlais,Carsten J. Schubert,Carl Crysler,Yanmin Chen,Christopher J. Molloy,Margery A. Chaikin,Carl L. Manthey,Mark R. Player,Bruce E. Tomczuk,Carl R. Illig	26
4	Discovery of novel FMS kinase inhibitors as anti-inflammatory agents 2008 ·Bioorganic & Medicinal Chemistry Letters ·Carl R. Illig,(unknown),Mark J. Wall,Kenneth J. Wilson,Shelley K. Ballentine,Matthias Rudolph,Renée L. DesJarlais,Yanmin Chen,Carsten J. Schubert,Ioanna P. Petrounia,Carl Crysler,Christopher J. Molloy,Margery A. Chaikin,Carl L. Manthey,Mark R. Player,Bruce E. Tomczuk,Sanath K. Meegalla	40
5	Orally efficacious thrombin inhibitors with cyanofluorophenylacetamide as the P2 motif 2008 ·Bioorganic & Medicinal Chemistry Letters ·K. D. Kreutter,Tianbao Lu,Lily Lee,Edward C. Giardino,Sharmila Patel,Hui Huang,Guozhang Xu,Mark Fitzgerald,Barbara J. Haertlein,V. Mohan,Carl Crysler,Stephen Eisennagel,Malini Dasgupta,Martin McMillan,John Spurlino,Norman Huebert,Bruce E. Maryanoff,Bruce E. Tomczuk,Bruce P. Damiano,Mark R. Player	24
6	Pharmacokinetics of TDP223206 following intravenous and oral administration to intact rats and intravenous administration to bile duct‐cannulated rats 2008 ·Biopharmaceutics & Drug Disposition ·Yanmin Chen,(unknown),Juan Marugán,Carl L. Manthey,Bruce E. Tomczuk,Norman Huebert	1
7	Carboxylic acid bioisosteres acylsulfonamides, acylsulfamides, and sulfonylureas as novel antagonists of the CXCR2 receptor 2008 ·Bioorganic & Medicinal Chemistry Letters ·Michael P. Winters,Carl Crysler,Nalin L. Subasinghe,Declan Ryan,(unknown),Shuyuan Zhao,Robert R. Donatelli,Edward J. Yurkow,(unknown),(unknown),Carl L. Manthey,Christopher J. Molloy,(unknown),Lynne A. Murray,(unknown),Bruce E. Tomczuk	28
8	Pharmacokinetic properties of TDP4815 after single intravenous and oral administrations to rat, rabbit, monkey, dog andin vitrodrug metabolism 2008 ·Biopharmaceutics & Drug Disposition ·Yanmin Chen,(unknown),(unknown),(unknown),Stephen Eisennagel,Malini Dasgupta,Bruce E. Tomczuk,Roger Bone,Norman Huebert	1
9	Identification of novel short chain 4-substituted indoles as potent αvβ3 antagonist using structure-based drug design 2006 ·European Journal of Medicinal Chemistry ·Pierre Raboisson,Renée L. DesJarlais,(unknown),Jennifer Lattanze,Margery A. Chaikin,Carl L. Manthey,Bruce E. Tomczuk,Juan Marugán	18
10	Novel potent and selective αvβ3/αvβ5 integrin dual antagonists with reduced binding affinity for human serum albumin 2006 ·European Journal of Medicinal Chemistry ·Pierre Raboisson,Carl L. Manthey,Margery A. Chaikin,Jennifer Lattanze,Carl Crysler,Kristi Leonard,Wenxi Pan,Bruce E. Tomczuk,Juan Marugán	10
11	A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1s 2006 ·Bioorganic & Medicinal Chemistry Letters ·Nalin L. Subasinghe,Jeremy Travins,(unknown),Hui Huang,Shelley K. Ballentine,Juan Marugán,Ehab M. Khalil,(unknown),Roger Bone,Renée L. DesJarlais,Carl Crysler,(unknown),Maxwell D. Cummings,Christopher J. Molloy,Bruce E. Tomczuk	11
12	Non-peptidic αvβ3 antagonists containing indol-1-yl propionic acids 2005 ·Bioorganic & Medicinal Chemistry Letters ·Kristi Leonard,Wenxi Pan,(unknown),(unknown),(unknown),Renée L. DesJarlais,(unknown),Jennifer Lattanze,Carl Crysler,Carl L. Manthey,Bruce E. Tomczuk,Juan Marugán	20
13	A functional radioreceptor assay of alpha-V-beta-3 (αvβ3) inhibitors in plasma: Application as an ex vivo pharmacodynamic model 2005 ·Journal of Biochemical and Biophysical Methods ·Margery A. Chaikin,Juan Marugán,Gerald W. De Vries,Peter Baciu,Jeffrey L. Edelman,Ming Ni,Bruce E. Tomczuk,Wenxi Pan,(unknown),(unknown),Kristi Leonard,Stephen Eisennagel,Christopher J. Molloy,Carl L. Manthey	1
14	Oxyguanidines: application to non-peptidic phenyl-based thrombin inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Bruce E. Tomczuk,Tianbao Lu,Richard Söll,(unknown),Aihua Wang,(unknown),Carl Crysler,Malini Dasgupta,Stephen Eisennagel,John Spurlino,Roger Bone	24
15	Amidinohydrazones as guanidine bioisosteres: application to a new class of potent, selective and orally bioavailable, non-amide-based small-molecule thrombin inhibitors 2000 ·Bioorganic & Medicinal Chemistry Letters ·Richard Söll,(unknown),Bruce E. Tomczuk,Carl R. Illig,(unknown),Stephen Eisennagel,Roger Bone,(unknown),John Spurlino,F. Raymond Salemme	33
16	In vitro evaluation and crystallographic analysis of a new class of selective, non-amide-based thrombin inhibitors 1998 ·Bioorganic & Medicinal Chemistry Letters ·Tianbao Lu,Bruce E. Tomczuk,Carl R. Illig,Roger Bone,(unknown),John Spurlino,F. Raymond Salemme,Richard Söll	20
17	Inhibition of Matrix Metalloproteinases by Hydroxamates Containing Heteroatom-Based Modifications of the P1' Group 1995 ·Journal of Medicinal Chemistry ·Madhusudhan Gowravaram,Jeffrey S. Johnson,(unknown),Ewell R. Cook,Bruce E. Tomczuk,Arup K. Ghose,Alan M. Mathiowetz,John Spurlino,Byron Rubin,Douglas L. Smith,(unknown),Robert C. Wahl	48
18	Synthesis and substance P antagonist activity of naphthimidazolium derivatives 1992 ·Journal of Medicinal Chemistry ·(unknown),(unknown),Kenneth C. Appell,(unknown),(unknown),Bruce E. Tomczuk,John M. Yanni	13
19	2-Phenyl-3H-imidazo[4,5-b]pyridine-3-acetamides as nonbenzodiazepine anticonvulsants and anxiolytics 1991 ·Journal of Medicinal Chemistry ·Bruce E. Tomczuk,(unknown),(unknown),(unknown),Young S. Lo,David N. Johnson,(unknown),Brian F. Kilpatrick	53
20	Measurement of tachykinin-induced salivation in conscious rats 1991 ·Journal of Pharmacological Methods ·(unknown),Bruce E. Tomczuk,John M. Yanni	2

About Bruce E. Tomczuk

Bruce E. Tomczuk is a scholar working on Immunology and Allergy, Anatomy and Hematology, having authored 37 papers that have together received 1.1k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (8 papers), Chemical Synthesis and Analysis (5 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). The work is most often cited by research in Organic Chemistry (416 citations), Oncology (396 citations) and Radiology, Nuclear Medicine and Imaging (239 citations). Bruce E. Tomczuk has collaborated with scholars based in United States and Belgium. Frequent co-authors include Sean W. Smith, Nareshkumar Jain, Carl Crysler, John Spurlino, Tianbao Lu, Carl L. Manthey, Mark R. Player, Renée L. DesJarlais, Kenneth C. Appell and Roger Bone. Their work appears in journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Molecular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact